Chinese DENOVO PD Registry
Recruiting · NCT05767151 · Observational (researchers observe without assigning treatment) · Lead sponsor: Xiangya Hospital of Central South University
View the official record on ClinicalTrials.gov →What this trial is about
The main objective of this longitudinal, multi-center study is to explore the clinical characteristics of PD and confirm biomarkers for PD evolution or progression.
Who can take part
Age range
30 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Participants were diagnosed by MDS Clinical Diagnostic Criteria for PD
- Disease duration ≤ 2 years at baseline
- Hoehn-Yahr stage ≤2 at baseline
- The age of PD patients ranges from 30 to 75 years old
- Participants were naive to antiparkinsonian therapy
- Able to Written informed consent
Exclusion criteria
- Participants were diagnosed with parkinsonism-syndrome
- Participants were treated with antiparkinsonian drugs at baseline
- Participants with cognitive impairment
- Unable to Written informed consent
Where it is running
1 location listed.
- Xiangya Hospital of Central South University - Changsha, Hunan, China